Personalized Rx Leaders Head up New Cancer PGx Company Foundation Medicine

Foundation Medicine has raised $25 million in Series A financing that it will use to "broadly analyze the relevant tumor genomic and other molecular information in individual patients' cancers and connect it with a knowledgebase of clinical data to help oncologists personalize treatment."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.